• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen.

作者信息

Reddy B S, Rivenson A

机构信息

Division of Nutritional Carcinogenesis, American Health Foundation, Valhalla, New York 10595.

出版信息

Cancer Res. 1993 Sep 1;53(17):3914-8.

PMID:8358717
Abstract

The inhibitory effect of lyophilized cultures of Bifidobacterium longum on 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced carcinogenesis was investigated in male and female F344 rats. Beginning at 5 weeks of age, male and female rats were divided into various experimental groups and fed one of the high-fat, semipurified diets containing 0 and 0.5% lyophilized cultures of B. longum with or without 125 ppm IQ in the diet. All animals were continued on this regimen until the termination of the study. All animals were necropsied during the 58th week. The results indicated that dietary B. longum significantly inhibited the IQ-induced incidence (percentage of animals with tumors) of colon (100% inhibition) and liver (80% inhibition) tumors and multiplicity (tumors/animal) of colon, liver, and small intestinal tumors in male rats. In female rats, dietary supplementation of Bifidobacterium cultures also suppressed the IQ-induced mammary carcinogenesis to 50% and liver carcinogenesis to 27% of those observed in animals fed the control diet, but the differences did not reach a statistical significance at P < 0.05; however, the mammary tumor multiplicity (tumors/animal) was significantly (P < 0.05) inhibited in female rats fed the diet containing Bifidobacterium cultures. These findings suggest that Bifidobacterium supplements in the diet inhibit IQ-induced colon and liver tumors and to a lesser extent mammary tumors in F344 rats.

摘要

相似文献

1
Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen.
Cancer Res. 1993 Sep 1;53(17):3914-8.
2
Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.合成有机硒化合物1,4-亚苯基双(亚甲基)硒氰酸酯对结肠癌发生的化学预防作用。
Cancer Res. 1992 Oct 15;52(20):5635-40.
3
Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.在饮食中同时给予吡罗昔康(一种非甾体抗炎药)和D,L-α-二氟甲基鸟氨酸(一种鸟氨酸脱羧酶抑制剂)对结肠癌发生进行化学预防。
Cancer Res. 1990 May 1;50(9):2562-8.
4
Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial beta-glucuronidase.长双歧杆菌培养物对氧化偶氮甲烷诱导的异常隐窝灶形成及粪便细菌β-葡萄糖醛酸酶的抑制作用。
Proc Soc Exp Biol Med. 1994 Dec;207(3):278-83. doi: 10.3181/00379727-207-43817.
5
Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.通过单独及联合饮食给予吡罗昔康、α-二氟甲基鸟氨酸、16α-氟-5-雄甾烯-17-酮和鞣花酸对结肠癌发生进行化学预防。
Cancer Res. 1991 Sep 1;51(17):4528-34.
6
Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development.在大鼠结肠肿瘤发展的不同阶段,非甾体抗炎药吡罗昔康通过饮食给药对结肠癌发生具有剂量相关的抑制作用。
Cancer Res. 1987 Oct 15;47(20):5340-6.
7
Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis.长双歧杆菌,一种产生乳酸的肠道细菌,可抑制结肠癌并调节结肠癌发生的中间生物标志物。
Carcinogenesis. 1997 Apr;18(4):833-41. doi: 10.1093/carcin/18.4.833.
8
Effects of sucrose and cornstarch on 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colon and liver carcinogenesis in F344 rats.蔗糖和玉米淀粉对F344大鼠中2-氨基-3-甲基咪唑[4,5-f]喹啉(IQ)诱导的结肠癌和肝癌发生的影响。
Cancer Lett. 2004 Jun 8;209(1):17-24. doi: 10.1016/j.canlet.2003.12.008.
9
Effect of dietary corn bran and autohydrolyzed lignin on 3,2'-dimethyl-4-aminobiphenyl-induced intestinal carcinogenesis in male F344 rats.日粮玉米麸皮和自水解木质素对3,2'-二甲基-4-氨基联苯诱导的雄性F344大鼠肠道癌变的影响。
J Natl Cancer Inst. 1983 Aug;71(2):419-23.
10
Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.膳食脂肪酸的类型和数量对实验性结肠肿瘤发生的调节作用。
Cancer Res. 2001 Mar 1;61(5):1927-33.

引用本文的文献

1
Microbial Signatures in Breast Cancer: Exploring New Potentials Across Body Niches.乳腺癌中的微生物特征:探索全身生态位的新潜力
Int J Mol Sci. 2025 Sep 5;26(17):8654. doi: 10.3390/ijms26178654.
2
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy.涉及结直肠癌的信号通路:发病机制和靶向治疗。
Signal Transduct Target Ther. 2024 Oct 7;9(1):266. doi: 10.1038/s41392-024-01953-7.
3
The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice.肠道微生物群失调-癌症轴:为临床实践提供新见解和启示
Front Pharmacol. 2023 Jun 9;14:1208044. doi: 10.3389/fphar.2023.1208044. eCollection 2023.
4
Beneficial insights into postbiotics against colorectal cancer.关于后生元抗结直肠癌的有益见解。
Front Nutr. 2023 Mar 10;10:1111872. doi: 10.3389/fnut.2023.1111872. eCollection 2023.
5
Structural features, interaction with the gut microbiota and anti-tumor activity of oligosaccharides.低聚糖的结构特征、与肠道微生物群的相互作用及抗肿瘤活性
RSC Adv. 2020 Apr 24;10(28):16339-16348. doi: 10.1039/d0ra00344a. eCollection 2020 Apr 23.
6
Effects of KLDS1.0901 on Proliferation and Apoptosis of Colon Cancer Cells.KLDS1.0901对结肠癌细胞增殖和凋亡的影响
Front Microbiol. 2022 Feb 11;12:788040. doi: 10.3389/fmicb.2021.788040. eCollection 2021.
7
Antimutagenic Activity as a Criterion of Potential Probiotic Properties.抗诱变活性作为潜在益生菌特性的一个标准。
Probiotics Antimicrob Proteins. 2022 Dec;14(6):1094-1109. doi: 10.1007/s12602-021-09870-9. Epub 2022 Jan 14.
8
Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics.益生菌、益生元和合生菌:下一代治疗药物的安全选择。
Appl Microbiol Biotechnol. 2022 Jan;106(2):505-521. doi: 10.1007/s00253-021-11646-8. Epub 2022 Jan 11.
9
Recent Development of Probiotic for Treating Human Diseases.用于治疗人类疾病的益生菌的最新进展。
Front Bioeng Biotechnol. 2021 Dec 22;9:770248. doi: 10.3389/fbioe.2021.770248. eCollection 2021.
10
Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies.癌症治疗期间针对肠道微生物群的营养干预措施。
Microorganisms. 2021 Jul 9;9(7):1469. doi: 10.3390/microorganisms9071469.